
Inrepa D 30mg/20mg Capsule SR
Marketer
Classic Healthcare Labs
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Inrepa D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD), or acid reflux, can be managed with Inrepa D 30mg/20mg SR capsules, a dual-action formulation. This medication alleviates symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion, thus easing discomfort. Inrepa D should be taken on an empty stomach, following your physician's prescribed dosage and duration. Treatment length depends on individual response and condition severity; premature discontinuation may lead to symptom recurrence and potential worsening. Always inform your doctor of all other medications you are using, as interactions may occur. Common side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue, most of which are transient. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or tasks requiring alertness until the effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding caffeinated beverages, spicy foods, and chocolate, may enhance treatment efficacy. Prior to commencing treatment, disclose any kidney or liver conditions, and inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Inrepa D 30mg/20mg Capsule SR
The provided text is "undefined," therefore no rewriting is possible.
Uses of Inrepa D 30mg/20mg Capsule SR
Managing acid reflux and peptic ulcers.
Major Benefits of Inrepa D 30mg/20mg Capsule SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Inrepa D 30mg/20mg sustained-release capsules should be taken on an empty stomach.
Common Side effects of Inrepa D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Inrepa D 30mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or breaking it. Inrepa D 30mg/20mg Sustained-Release Capsules should be taken on an empty stomach.
How Inrepa D 30mg/20mg Capsule SR works:
Inrepa D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole. Domperidone, a gastrointestinal motility stimulant, enhances upper digestive tract movement, facilitating smoother food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, providing relief from acid indigestion and heartburn.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while taking Inrepa D 30mg/20mg SR Capsules. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of Inrepa D 30mg/20mg SR capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Consult your physician for advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Inrepa D 30mg/20mg capsule is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk with possible infant harm.
DrivingUNSAFE
Taking Inrepa D 30mg/20mg sustained-release capsules might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney disease should exercise caution when using Inrepa D 30mg/20mg sustained-release capsules. Dosage modification of Inrepa D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Inrepa D 30mg/20mg SR capsules cautiously, potentially requiring dosage modification. Medical advice is necessary. Inrepa D 30mg/20mg SR capsules are unsuitable for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Inrepa D 30mg/20mg Capsule SR :
Should you forget to take your Inrepa D 30mg/20mg SR Capsule, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Inrepa D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
